Edition:
United Kingdom

Deciphera Pharmaceuticals Inc (DCPH.OQ)

DCPH.OQ on NASDAQ Stock Exchange Global Select Market

38.32USD
6:20pm BST
Change (% chg)

$-0.99 (-2.52%)
Prev Close
$39.31
Open
$39.59
Day's High
$40.66
Day's Low
$37.76
Volume
28,531
Avg. Vol
69,224
52-wk High
$45.61
52-wk Low
$15.37

Chart for

About

Deciphera Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing drugs to improve the lives of cancer patients. Its drug candidate includes DCC-2618, DCC-3014 and Rebastinib. Its proprietary kinase switch control inhibitor platform, inhibit the activation of kinases. DCC-2618, an orally... (more)

Overall

Beta: --
Market Cap(Mil.): $702.77
Shares Outstanding(Mil.): 30.68
Dividend: --
Yield (%): --

Financials

  DCPH.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -1.08 -- --
ROI: -- 1.78 14.61
ROE: -- 3.27 16.33

Earnings vs. Estimates